Pancreatic Cancer Research

ResearcherRenmin Hospital of Wuhan UniversityActive in the last 2 years

Long-Jiang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8313-5909; OpenAlex author ID A5090166612. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper

Papers 3

  1. Curcumin inhibits the invasion and migration of pancreatic cancer cells by upregulating TFPI-2 to regulate ERK- and JNK-mediated epithelial-mesenchymal transit… Co-author DOI 10.1007/s00394-023-03296-5↗
  2. m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Co-author DOI 10.1080/15592294.2022.2061117↗
  3. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β. Co-author DOI 10.3892/ijo.2022.5406↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulu Zhai · 3 shared papers, 2022–2024 · strength 0.60
  2. Wei Wang · 2 shared papers, 2022–2024 · strength 0.42
  3. Lun Wu · 2 shared papers, 2022 · strength 0.34
  4. Tong-Fa Ju · 1 shared paper, 2024 · strength 0.26
  5. Dalong Yin · 1 shared paper, 2024 · strength 0.26
  6. Zhi‐Gang Tang · 1 shared paper, 2022 · strength 0.17
  7. Zhi‐Gang Tang · 1 shared paper, 2022 · strength 0.16
  8. Lichao Yao · 1 shared paper, 2022 · strength 0.16
  9. Jinzhuo Ning · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.